ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,031Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 381

$4.97M Total Retail Price of All Prescriptions

Rank: 1 out of 381

609 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

4% of this provider’s 14,910 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

70% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$248 was the average price of a prescription from this provider, compared to $112 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
ADVAIR DISKUS 974 710 1 57
LOVAZA 775 565 2 50
ABILIFY 728 531 3 89
LIDODERM 667 459 4 79
SINGULAIR 655 461 5 72
EXELON 601 418 6 95
MEGACE ES 591 439 R 10 7 99
SEROQUEL XR 561 407 8 100
NEXIUM 559 430 9 41
NAMENDA 532 390 10 69
CELEBREX 441 305 11 104
CYMBALTA 428 321 12 83
DOVONEX 395 279 10 13 120
CALCIPOTRIENE 365 256 10 14 125
DEXILANT 351 269 15 118
SOLARAZE 346 262 16 128
PLAVIX 308 227 17 46
IBUPROFEN 297 202 18 92
ESCITALOPRAM OXALATE 289 220 19 91
SYMBICORT 287 190 20 121
CRESTOR 282 211 21 29
DIOVAN HCT 247 172 22 94
SEROQUEL 246 175 23 148
OLANZAPINE 233 171 24 152
AGGRENOX 231 157 10 25 155
QUETIAPINE FUMARATE 230 153 26 137
DIOVAN 216 173 27 18
CLOPIDOGREL 211 171 28 44
OMEPRAZOLE 193 135 29 13
LISINOPRIL 187 168 30 3
LEVOTHYROXINE SODIUM 178 136 31 16
METFORMIN HCL 158 133 32 27
SIMVASTATIN 155 140 33 8
MONTELUKAST SODIUM 150 119 34 140
VOLTAREN 145 105 35 153
DONEPEZIL HCL 134 106 36 59
CLARITHROMYCIN ER 130 76 10 37 193
PENTOXIFYLLINE 125 87 38 102
ZYPREXA 121 92 39 199
FUROSEMIDE 118 99 40 2
RESTASIS 116 69 41 202
SORIATANE 111 85 10 42 205
LEXAPRO 107 84 43 162
ACTOS 106 70 44 129
LYRICA 105 77 45 124
ATORVASTATIN CALCIUM 104 98 46 19
METRONIDAZOLE 97 55 47 215
METOPROLOL TARTRATE 97 96 47 11
AVODART 94 70 49 180
TRAMADOL HCL 89 74 50 34
NASONEX 87 58 51 167
PAROXETINE HCL 86 65 52 107
ATENOLOL 83 80 53 30
IMIQUIMOD 83 52 53 219
COMBIVENT 81 61 55 166
TRICOR 80 50 56 113
ALLOPURINOL 79 77 57 10
NAFTIN 78 37 58 222
JANUVIA 77 42 59 55
METAXALONE 77 57 R 10 59 225
ZOVIRAX 76 48 61 226
VENLAFAXINE HCL ER 76 51 61 226
DICLOFENAC SODIUM 76 54 61 226
WARFARIN SODIUM 76 52 61 38
SPIRIVA 75 49 65 136
BONIVA 75 71 65 184
CARVEDILOL 74 52 67 9
AMLODIPINE BESYLATE 70 52 68 1
LIPITOR 68 53 69 109
GLYBURIDE-METFORMIN HCL 67 62 R 70 194
TAMSULOSIN HCL 64 40 71 42
MUPIROCIN 63 56 72 151
PANTOPRAZOLE SODIUM 63 47 72 45
CIPROFLOXACIN HCL 63 56 72 78
VESICARE 62 42 75 177
SYNTHROID 58 51 76 68
RIVASTIGMINE 58 48 76 251
ASACOL 58 43 76 251
HYDROCHLOROTHIAZIDE 56 49 79 22
GABAPENTIN 56 52 79 33
LANTUS SOLOSTAR 55 38 81 105
ZETIA 54 46 82 81
CLOTRIMAZOLE-BETAMETHASONE 53 41 83 270
NOVOLOG FLEXPEN 51 34 84 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 6, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.